Letter to the Editor
In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?
Gabriel T. Cubaa,b,1,
, Paulo H.D. Santosa,1, Antonio C.C. Pignataria, David P. Nicolauc, Carlos R.V. Kiffera
Corresponding author
a Universidade Federal de São Paulo (UNIFESP), Escola Paulista de Medicina, São Paulo, SP, Brazil
b Universidade de São Paulo (HCFMUSP), Hospital das Clínicas, Faculdade de Medicina, São Paulo, SP, Brazil
c Center of Anti-infective Research and Development, Hartford Hospital, Hartford, CT, United States
Read
2362
Timeswas read the article
1106
Total PDF
1256
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 11 | 17 | 28 |
| 2024 October | 27 | 35 | 62 |
| 2024 September | 35 | 28 | 63 |
| 2024 August | 47 | 33 | 80 |
| 2024 July | 45 | 32 | 77 |
| 2024 June | 42 | 34 | 76 |
| 2024 May | 35 | 36 | 71 |
| 2024 April | 41 | 31 | 72 |
| 2024 March | 35 | 31 | 66 |
| 2024 February | 40 | 33 | 73 |
| 2024 January | 28 | 36 | 64 |
| 2023 December | 26 | 37 | 63 |
| 2023 November | 48 | 47 | 95 |
| 2023 October | 35 | 46 | 81 |
| 2023 September | 46 | 54 | 100 |
| 2023 August | 30 | 32 | 62 |
| 2023 July | 25 | 28 | 53 |
| 2023 June | 25 | 14 | 39 |
| 2023 May | 35 | 33 | 68 |
| 2023 April | 27 | 22 | 49 |
| 2023 March | 58 | 36 | 94 |
| 2023 February | 41 | 36 | 77 |
| 2023 January | 36 | 25 | 61 |
| 2022 December | 65 | 33 | 98 |
| 2022 November | 59 | 54 | 113 |
| 2022 October | 54 | 36 | 90 |
| 2022 September | 36 | 41 | 77 |
| 2022 August | 42 | 43 | 85 |
| 2022 July | 36 | 34 | 70 |
| 2022 June | 80 | 54 | 134 |
| 2022 May | 63 | 49 | 112 |
| 2022 April | 3 | 6 | 9 |
Show all
